SiteOne Therapeutics Raises $15M
Bozeman, Montana-based SiteOne Therapeutics said on Friday that it has raised $15M in a Series B investment round. The funding was led by Amgen, and also included Next Frontier and other investors. SiteOne is developing no-opioid analgesics, aimed at treating chronic pain without causing addition. The company is led by President and CEO Stan E. Abel.
posted on Monday, January 9, 2017 (Link to more information)
Related companies:
SiteOne Therapeutics, Inc.
Related stories:
> SiteOne Therapeutics Gets Investment Round
> Insys Therapeutics Files For IPO
> Miragen Therapeutics Raises $8M
> Merck Buys Sirna Therapeutics
> BaroFold Raises $12M
Techrockies.com Home